For following the competition: what moved in each program, several studies read as one move.
- SH006
- PRMT5 Inhibitor SH3765
- SH009
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Nanjing Sanhome Pharmaceutical to watchlistEvery Monday by email · turn it off any timePro · free during the beta